Welcome to our dedicated page for Oscar Health SEC filings (Ticker: OSCR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Oscar Health, Inc. filings document the public-company disclosures of a healthcare technology and health insurance issuer listed on the New York Stock Exchange under Class A common stock symbol OSCR. Its Form 8-K reports cover operating results, guidance updates, Regulation FD disclosures, material agreements and capital-structure transactions, including credit facilities, convertible notes and debt exchanges.
The company’s proxy materials disclose annual meeting matters, board governance, director elections and executive compensation. Other filings address executive employment arrangements, registered securities, risk language tied to competition, artificial intelligence and machine-learning models, internal controls and the company’s use of technology to support Individual & Family plans, +Oscar services and related healthcare marketplace offerings.
OSCR reported insider sale activity and option-related exercises. A reported sale of 34,120 shares on 06/02/2026 generated $748,633.08. The filing also lists planned/related option exercises: 660,000 shares tied to an Exercise of Stock Options dated 06/23/2026 and 220,000 shares from a prior exercise dated 11/16/2023.
Mario Schlosser reports proposed sale of 95,000 shares of Common Stock. The Form 144 lists Morgan Stanley Smith Barney LLC as the broker and indicates an aggregate value of $2,711,300.00 with an execution venue of NYSE and a date shown as 06/23/2026. The filing also discloses prior sales of 34,120 shares on 06/02/2026 for $748,633.08.
Oscar Health, Inc. reported the results of its 2026 Annual Meeting of Stockholders. Stockholders elected eight directors to serve until the 2027 Annual Meeting, with each nominee receiving over 770 million votes when including high-vote Class B shares.
Stockholders approved, on an advisory basis, the compensation of the company’s named executive officers, with 765,188,330 votes in favor, 8,859,050 against, and 329,648 abstaining. They also ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026, with 819,470,681 votes for and 710,425 against.
Lang Laura W reported acquisition or exercise transactions in this Form 4 filing.
Oscar Health, Inc. director Laura W. Lang received a grant of 8,475 restricted stock units (RSUs) of Class A common stock at no cash cost. Each RSU represents one share and vests on the earlier of the one-year anniversary of the grant date or the next annual stockholder meeting, subject to continued service. Vested RSUs are settled in shares after separation, death, disability, or within days following a change in control. After this award, Lang directly holds 82,840 shares, including these RSUs.
Plouffe David reported acquisition or exercise transactions in this Form 4 filing.
Oscar Health, Inc. reported that director David Plouffe received a grant of 8,475 restricted stock units (RSUs) tied to its Class A common stock. Following this equity award, his reported direct holdings total 137,121 shares.
The RSUs vest on the earlier of the one-year anniversary of the grant date or the next annual stockholders’ meeting, assuming continued service. Once vested, they are settled in Class A shares upon specified events such as separation from service, death, disability, or a change in control.
Sankaran Sid reported acquisition or exercise transactions in this Form 4 filing.
Oscar Health, Inc. director Sid Sankaran reported an equity award and updated holdings. He received 8,475 shares of Class A common stock as a grant of restricted stock units (RSUs) at no cash cost, bringing his directly held shares to 22,609.
Each RSU represents one share of Class A common stock and vests on the earlier of the one-year anniversary of the grant date or the next annual stockholder meeting, subject to continued service. Vested RSUs settle in shares after certain separation, disability, death, or change-in-control triggers.
Separately, 795,686 shares of Class A common stock are held indirectly by Victoria Family LLC, which is wholly owned by fiduciaries of The Victoria 2020 Trust. Sankaran acts as investment adviser to the trust and disclaims beneficial ownership of those shares except for his pecuniary interest.
Oscar Health director William Gassen received an equity award of 8,475 restricted stock units (RSUs) of Class A common stock. The grant has no cash exercise price and is part of his director compensation, not an open-market purchase.
The RSUs vest on the earlier of the one-year anniversary of the grant date or the next annual stockholder meeting, as long as he remains in service through that date. Once vested, shares will be delivered after separation, death, disability, or within a few days following a change in control, under the timing rules described. After this grant, he holds 82,840 shares directly.
WITTMAN VANESSA AMES reported acquisition or exercise transactions in this Form 4 filing.
Oscar Health director Vanessa Ames Wittman received a grant of 8,475 restricted stock units (RSUs) of Class A common stock as equity compensation. The award was made at no cash cost per share and is structured as RSUs rather than an open-market purchase.
The RSUs vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders, provided she continues serving through that date. Once vested, they are settled in Class A shares after separation, death, disability, or shortly following a change in control, as specified.
Following this grant, Wittman directly holds 137,121 shares (including RSUs) of Oscar Health Class A common stock.
Oscar Health, Inc. announced it will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, where it plans to provide a business update and reaffirm its full year 2026 guidance previously issued on February 10, 2026.
A live audio webcast will be available on the company’s investor relations website, with a replay accessible for about 90 days. The company also reminds readers that statements about expected financial performance are forward-looking and subject to risks described in its Form 10-K for 2025 and Form 10-Q for the quarter ended March 31, 2026.
Oscar Health, Inc. Chief Accounting Officer Victoria Baltrus reported selling 1,523 shares of Class A common stock on June 2, 2026 in two open-market transactions at weighted-average prices around $21–$23. According to the disclosure, these sales were made under a Rule 10b5-1 instruction letter to satisfy tax withholding obligations from previously vested equity awards. After the transactions, she continues to directly hold about 214,589 shares, so the sale represents a small portion of her overall position.